2-Adrenergic Agonists Suppress Rat Autoimmune Myocarditis: Potential Role of 2-Adrenergic Stimulants as New Therapeutic Agents for Myocarditis

Circulation - United States
doi 10.1161/circulationaha.105.607903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

SARS-CoV-2: A Potential Novel Etiology of Fulminant Myocarditis

Herz
Cardiovascular MedicineCardiology
2020English

Time Course of Gene Expression in Rat Experimental Autoimmune Myocarditis

Clinical Science
Medicine
2002English

Resveratrol Ameliorates Experimental Autoimmune Myocarditis

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2003English

Role of 2 Adrenergic Receptors in Human Atherosclerotic Coronary Arteries

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Exogenous Thioredoxin Reduces Inflammation in Autoimmune Myocarditis

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Biarylaniline Phenethanolamines as Potent and Selective B3 Adrenergic Receptor Agonists

English

Efficacy of Beta 1-Adrenergic Receptors Is Lower Than That of Beta 2-Adrenergic Receptors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Altered Pharmacological Effects of Adrenergic Agonists During Hypothermia

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Critical CareEmergency MedicineIntensive Care Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy